Evidence map›Paper›PMID 39962309›Full record

ArticleScientific reports2025

Impact of Covid-19 pandemic on trajectories of patients with severe alcohol use disorder treated with disulfiram.

Maximilian Pilhatsch, Max Schallenberg, Diana Vogel-Blaschka, Ariana-Berenike Treu, Johannes Petzold, Lena Zander, Maik Spreer

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Substance use disorders and addictions.Scientific reports · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Maximilian PilhatschDepartment of Psychiatry and Psychotherapy, University Hospital Dresden, TUD Dresden University of Technology, Dresden, Germany. Maximilian.pilhatsch@ukdd.de.ORCID 0000-0003-4323-3309
Max SchallenbergDepartment of Psychiatry and Psychotherapy, University Hospital Dresden, TUD Dresden University of Technology, Dresden, Germany.ORCID 0009-0002-7472-9649
Diana Vogel-BlaschkaDepartment of Psychiatry and Psychotherapy, Elblandklinikum Radebeul, Radebeul, Germany.ORCID 0000-0002-9674-3874
Ariana-Berenike TreuDepartment of Psychiatry and Psychotherapy, Elblandklinikum Radebeul, Radebeul, Germany.
Johannes PetzoldDepartment of Psychiatry and Psychotherapy, University Hospital Dresden, TUD Dresden University of Technology, Dresden, Germany.ORCID 0000-0003-4163-9014
Lena ZanderDepartment of Psychiatry and Psychotherapy, Elblandklinikum Radebeul, Radebeul, Germany.
Maik SpreerDepartment of Psychiatry and Psychotherapy, University Hospital Dresden, TUD Dresden University of Technology, Dresden, Germany.ORCID 0000-0001-8436-8520

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The manifestations and progression of alcohol use disorder (AUD) are influenced by a number of contextual factors, with the current coronavirus pandemic being a significant example. This pandemic has profoundly impacted nearly all aspects of human life and has, therefore, strongly influenced patients suffering from AUD. In some cases, the pandemic has led to a reduction in severity, while in others, it has had the opposite effect. In our own work we have been investigating the negative impact of the pandemic on 45 patients with AUD who were undergoing outpatient treatment, including supervised use of disulfiram (Antabuse), in a close-knit program. A linear trend analysis demonstrated significant alterations in the retention rate over a 3-year period, encompassing the pre-pandemic, pandemic, and post-pandemic periods. During the pandemic the number of treatment cancellations virtually increased. Following the pandemic, a tendency towards the normalization of patient numbers was observed. Our data indicate a high level of vulnerability among patients with severe AUD and highlight a need for the development of alternative, possibly telemedical, treatment methods.

Indexed as

Alcohol DeterrentsAlcoholismCOVID-19DisulfiramAdultFemaleHumansMaleMiddle AgedPandemicsSARS-CoV-2Alcohol DeterrentsDisulfiramAlcohol use disorderAntabuseDisulfiramEnvironmental risk factorLinear trend analysisPandemic

Identifiers

PMID39962309
PMCPMC11832757

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.